SS
Therapeutic Areas
Jubilant Pharmova Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Oncology Injectables Portfolio | Various Cancers | ANDA Filed/Approved |
| Radiopharmaceuticals (Theragnostics) | Prostate Cancer, Neuroendocrine Tumors | Clinical/Commercial |
| REMOXY (oxycodone) ER | Chronic Pain | NDA Resubmitted |
| Complex Generic APIs | CNS, Cardiovascular, Metabolic | Development |
| Allergy Immunotherapy (SLIT) | Ragweed/Grass Pollen Allergy | Marketed/Development |
| Biosimilars Pipeline | Immunology, Oncology | Early Development |
Leadership Team at Jubilant Pharmova
HS
Hari S Bhartia
Co-Chairman and Co-Founder
PY
Pramod Yadav
Chief Executive Officer
AS
Ajit S. Kamath
President, API Business
RS
Rahul S. Bhartia
Member of the Board
AK
Ashish K. Bhargava
Chief Financial Officer
DS
Dr. Shyam B. Ghodawat
President, Global Quality & Operations